Racial differences in ceramides, cardiovascular health and cardiovascular risk: A preliminary analysis

20260 citationsJournal Articlegold Open Access

Authors

Mathias Lalika · Mayo Clinic

Vlad C. Vasile · Mayo Clinic

Matthew P. Johnson · Mayo Clinic in Florida

Sharonne N. Hayes · Mayo Clinic

Clarence Jones · Hmong American Partnership

Lisa A. Cooper · Johns Hopkins University

Christi A. Patten ·

Abstract

No association was observed between ceramide scores and CVH or ASCVD risk in African-American adults. Despite having a less favorable cardiometabolic profile, African-Americans exhibited lower ceramide levels than White adults. These findings suggest that ceramide scores may not accurately reflect cardiovascular risk in African-American populations.

Topics & Keywords

Sphingolipid Metabolism and Signaling Caveolin-1 and cellular processes Inflammation biomarkers and pathways

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Advances in Clinical and Experimental Medicine

Volume 35, Issue 7, pp. 0-0

DOI: 10.17219/acem/211134

Field-Weighted Citation Impact: 0.00